2 Result: Theratechnologies
Revised Outlook: Theratechnologies and AngioDynamics Fall Short
July 12th, 2023
Theratechnologies Inc. (Nasdaq: THTX) reported second-quarter fiscal 2023 revenue of $17.549 million, falling short of the consensus estimate of $20.32 million. The company attributes this lower-than-expected revenue to specialty pharmacy inventory a. Read more
Earnings Preview: MillerKnoll, AngioDynamics, and Theratechnologies
July 09th, 2023
On Wednesday, July 12, several companies are expected to report their financial results, including: MillerKnoll, Inc. (Nasdaq: MLKN), a consumer goods company, is set to release its financial results for the fourth quarter and full-year fiscal 202. Read more
Want To Find Some News?
News By Industries
Recent Post
-
December 05th, 2025
FDA Approves Nerve Scaffold for the Treatment of Sensory Nerve Discontinuity
December 04th, 2025December 02nd, 2025Earnings Countdown: Salesforce, Snowflake, and Guidewire Take Center Stage
November 30th, 2025Wall Street Eyes CrowdStrike, Marvell Technology, and GitLab as Earnings Near
November 30th, 2025
Member Login